Financial News:
Illumina
Illumina announced a higher than expected revenue forecast for 2022, citing robust demand for its gene sequencing procedures as well as new agreements with four health-caare businesses.
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Photo: Investors have seen no shortage of big watershed moments from DNA sequencing pioneer Illumina in recent years. The company's announcements of its refrigerator-sized human genome sequencing machines and its symbolic $1,000 human genome have grabbed the attention of observers and investors alike.
Content ID: 1641908895 Created Tuesday, January 11, 2022 1:48 PM UTC by Aaron Stipkovich, Updated Tuesday, January 11, 2022 2:16 PM UTC by Aaron Stipkovich.